How Food Processing Impacts Hyperkalemia and Hyperphosphatemia Management in Chronic Kidney Disease

被引:6
|
作者
Picard, Kelly [1 ,2 ]
Mager, Diana [1 ]
Richard, Caroline [1 ]
机构
[1] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada
[2] Alberta Hlth Serv, Nutr Serv, Edmonton, AB, Canada
关键词
CONSUMPTION; PHOSPHORUS; ADDITIVES; DIET; PREVALENCE; POTASSIUM; PRODUCTS; POULTRY; CANADA; SODIUM;
D O I
10.3148/cjdpr-2020-003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Food processing has a unique impact on patients living with chronic kidney disease who may need to restrict dietary sodium, potassium, and phosphorus intake. Canada is the second largest consumer of processed food in the world. Highly processed foods tend to be more nutrient dense, contain less fibre, and are higher in sodium than unprocessed foods. To reduce the amount of sodium in processed food, Health Canada has encouraged food producers to reduce the sodium in their food. Potassium additives have been identified as an attractive alternative to sodium and their use in food processing is expected to increase. Phosphorus additives have been reported to be present in about 44% of processed foods. Given the changes in the nutrient profiles of processed foods, dietary advice on ways to reduce sodium, potassium, and phosphorus intake may be best achieved by recommending minimally processed food and encouraging unprocessed foods more often.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [1] Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia
    Hannedouche, Thierry
    Fouque, Denis
    Joly, Dominique
    NEPHROLOGIE & THERAPEUTIQUE, 2018, 14 (06): : 6S17 - 6S25
  • [2] Hyperphosphatemia Management in Patients with Chronic Kidney Disease
    Shaman, Ahmed M.
    Kowalski, Stefan R.
    SAUDI PHARMACEUTICAL JOURNAL, 2016, 24 (04) : 494 - 505
  • [3] Advances in the management of hyperkalemia in chronic kidney disease
    Cowan, Andrea C. J.
    Gharib, Elie G.
    Weir, Matthew A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (03): : 235 - 239
  • [4] New developments in the management of hyperphosphatemia in chronic kidney disease
    McIntyre, Christopher W.
    SEMINARS IN DIALYSIS, 2007, 20 (04) : 337 - 341
  • [5] Hyperphosphatemia of chronic kidney disease
    Hruska, Keith A.
    Mathew, Suresh
    Lund, Richard
    Qiu, Ping
    Pratt, Raymond
    KIDNEY INTERNATIONAL, 2008, 74 (02) : 148 - 157
  • [6] PHOSPHATE BINDERS IN THE FOOD : A NOVEL THERAPEUTIC OPTION FOR THE MANAGEMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS
    Savica, Vincenzo
    Monardo, Paolo
    Bellinghieri, Guido
    Buemi, Michele
    Ricciardi, CarloAlberto
    Duro, Giovanni
    Santoro, Domenico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [7] Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
    Sarnowski, Alexander
    Gama, Rouvick M.
    Dawson, Alec
    Mason, Hannah
    Banerjee, Debasish
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2022, 15 : 215 - 228
  • [8] Pathophysiology and clinical management of hyperkalemia in chronic kidney disease
    Palmer, Biff F.
    Clegg, Deborah J.
    MINERVA MEDICA, 2023, 114 (05) : 719 - 735
  • [9] The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
    Shigematsu, Takashi
    Nakashima, Yuri
    Ohya, Masaki
    Tatsuta, Koichi
    Koreeda, Daisuke
    Yoshimoto, Wataru
    Yamanaka, Shintaro
    Sakaguchi, Toshifumi
    Hanba, Yoshiyuki
    Mima, Toru
    Negi, Shigeo
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2012, 5 : 81 - 89
  • [10] Hyperkalemia in chronic kidney disease
    Watanabe, Renato
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : S31 - S36